Jim Cramer Says “We Can Own The Stock of Pfizer (PFE)”

We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed recently.

A caller highlighted Pfizer Inc.’s (NYSE:PFE) promising drug pipeline, including multiple phase three candidates and a recent licensing deal with a Chinese biotech company. Cramer agreed and gave his blessing:

“Oh, they are. You know something, David, I’m with you. 7% yield. It’s got to be something big coming out of that Seagen acquisition real soon about some hard to beat cancers. I am with Albert Bourla and I am with you. I think we can own the stock of Pfizer.”

Jim Cramer Says "We Can Own The Stock of Pfizer (PFE)”

A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution.

Pfizer Inc. (NYSE:PFE) is a global pharmaceutical company best known for its vaccines and innovative therapies in oncology, immunology, and rare diseases.

Overall, PFE ranks 14th on our list of stocks that Jim Cramer discussed recently. While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PFE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.